Q4 2022 BioNTech SE Earnings Call Transcript
Welcome to the BioNTech Fourth Quarter and Year-End Update Call. I would now like to hand the call over to Michael Horowitz, Investor Relations and Strategy. Please go ahead, Michael.
Good morning and afternoon. Thank you for joining us today for BioNTech's Fourth Quarter and Full Year 2022 Earnings Call. As a brief reminder, the slides that accompany this call in the fourth quarter and full year 2022 press release that was issued this morning can be found in the Investors section of our website. As outlined on Slide 2, you can see our forward-looking statements disclaimer. Additional information about these statements and other risks are described in our filings made with the U.S. Securities and Exchange Commission, including our most recent annual report on Form 20-F. Forward-looking statements on the call are subject to substantial risks and uncertainties, speak only as of the call's original date, and we undertake no obligation to update or revise any of the statements.
On Slides 3 and 4, you can see detailed safety
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |